We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

83 hedge funds and large institutions have $573M invested in Dyne Therapeutics in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

14% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 21

9% more funds holding

Funds holding: 76 → 83 (+7)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1.15% less ownership

Funds ownership: 69.92% → 68.77% (-1.1%)

24% less capital invested

Capital invested by funds: $753M → $573M (-$180M)

Holders
83
Holders Change
+7
Holders Change %
+9.21%
% of All Funds
1.45%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
16
Increased
24
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
+$27.7M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.59M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.49M
4
Norges Bank
Norges Bank
Norway
+$2.08M
5
IBT
International Biotechnology Trust
United Kingdom
+$2.04M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$26.8M
2
DM
Deerfield Management
New York
-$16.6M
3
O
OrbiMed
New York
-$7.36M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$4.1M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
76
Tower Research Capital (TRC)
New York
$23K -$5.44K -307 -17%
SWM
77
Spire Wealth Management
Virginia
$13K +$7.09K +400 +100%
Federated Hermes
78
Federated Hermes
Pennsylvania
$13K +$13.7K +774 New
FF
79
FourThought Financial
Florida
$10K – – –
S
80
SignatureFD
Georgia
$1K +$869 +49 New
Nisa Investment Advisors
81
Nisa Investment Advisors
Missouri
$13 -$118K -6,682 -89%
DM
82
Deerfield Management
New York
– -$16.6M -787,000 Closed
O
83
OrbiMed
New York
– -$7.36M -350,000 Closed
Balyasny Asset Management
84
Balyasny Asset Management
Illinois
– -$4.1M -195,052 Closed
Alyeska Investment Group
85
Alyeska Investment Group
Illinois
– -$2.64M -125,566 Closed
TRSOTSOK
86
Teachers Retirement System of the State of Kentucky
Kentucky
– -$1.04M -49,275 Closed
MS
87
Maven Securities
Jersey
– -$798K -36,596 Closed
Tudor Investment Corp
88
Tudor Investment Corp
Connecticut
– -$489K -23,230 Closed
PCM
89
Pentwater Capital Management
Florida
– -$316K -15,000 Closed
Wells Fargo
90
Wells Fargo
California
– -$7K -323 Closed
HI
91
Harbour Investments
Wisconsin
– -$89 -5 -36%
UBS Group
92
UBS Group
Switzerland
– +$443 +25 New
1 2 3
4

DYN Hedge Fund Activity: Q3 2021 in Review

83 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q3 2021, worth a combined $573M — down 24% from $753M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new DYN positions and 9 closed out — a net gain of 7 holders — while 24 added to existing stakes and 21 trimmed.

The largest buyer was Logos Global Management, adding an estimated $27.7M. The largest seller was Wellington Management Group, cutting an estimated $26.8M.

  • 83 institutional investors held Dyne Therapeutics (DYN) as of Q3 2021, up from 76 in Q2 2021.
  • Funds reported $573M of Dyne Therapeutics stock for Q3 2021, down 24% quarter-over-quarter.
  • 16 funds opened new Dyne Therapeutics positions in Q3 2021 and 9 closed out, a net change of +7 holders.
  • The largest Dyne Therapeutics buyer in Q3 2021 was Logos Global Management, an estimated $27.7M added.
  • The largest Dyne Therapeutics seller in Q3 2021 was Wellington Management Group, an estimated $26.8M sold.

Based on aggregated 13F filings for Q3 2021.